• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virol J . RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling

tetano

Editor, Senior Moderator
Virol J


. 2022 Mar 5;19(1):39.
doi: 10.1186/s12985-022-01764-8.
RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling


Yixiang Hu[SUP] #[/SUP][SUP] 1 2 [/SUP], Qi Pan[SUP] #[/SUP][SUP] 1 [/SUP], Kun Zhou[SUP] 1 [/SUP], Yuehuan Ling[SUP] 1 [/SUP], Hao Wang[SUP] 1 [/SUP], Yan Li[SUP] #[/SUP][SUP] 3 4 5 [/SUP]



Affiliations

Abstract

Background: Influenza A viruses (IAVs) are zoonotic, segmented negative-stranded RNA viruses. The rapid mutation of IAVs results in host immune response escape and antiviral drug and vaccine resistance. RUNX1 is a transcription factor that not only plays essential roles in hematopoiesis, but also functions as a regulator in inflammation. However, its role in the innate immunity to IAV infection has not been well studied.
Methods: To investigate the effects of RUNX1 on IAV infection and explore the mechanisms that RUNX1 uses during IAV infection. We infected the human alveolar epithelial cell line (A549) with influenza virus A/Puerto Rico/8/34 (H1N1) (PR8) and examined RUNX1 expression by Western blot and qRT-PCR. We also knocked down or overexpressed RUNX1 in A549 cells, then evaluated viral replication by Western blot, qRT-PCR, and viral titration.
Results: We found RUNX1 expression is induced by IAV H1N1 PR8 infection, but not by poly(I:C) treatment, in the human alveolar epithelial cell line A549. Knockdown of RUNX1 significantly inhibited IAV infection. Conversely, overexpression of RUNX1 efficiently promoted production of progeny viruses. Additionally, RUNX1 knockdown increased IFN-β and ISGs production while RUNX1 overexpression compromised IFN-β and ISGs production upon PR8 infection in A549 cells. We further showed that RUNX1 may attenuate the interferon signaling transduction by hampering the expression of IRF3 and STAT1 during IAV infection.
Conclusions: Taken together, we found RUNX1 attenuates type I interferon signaling to facilitate IAV infection in A549 cells.

Keywords: A549; IFN; IRF3; Influenza A virus; RUNX1; STAT1.
 
Back
Top Bottom